"Northwestern Medicine is proud to have five hospitals ranked among “America’s Best” by U.S. News & World Report, 2021-22. Anchored by Northwestern Memorial Hospital, the #1 hospital in Illinois and a top 10 hospital in the nation, we’re leading the quest for better care and better treatments in the Chicagoland area. With more than 200 locations across Chicagoland, better care and better treatments are never far from home. To learn more, visit our website."

During the past decade, Northwestern Medicine Cancer Center Delnor conducted 88 clinical trials. In the 10-year time frame, 88 clinical trials started and 45 clinical trials were completed, i.e. on average, 51.1% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 35 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwestern Medicine Cancer Center Delnor" #1 sponsor was "National Cancer Institute (NCI)" with 66 trials, followed by "NRG Oncology" with 18 trials sponsored, "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwestern Medicine Cancer Center Delnor" #1 collaborator was "National Cancer Institute (NCI)" with 70 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Northwestern Medicine Cancer Center Delnor" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Ovarian Seromucinous Carcinoma" (6 trials), "Recurrent Ovarian Carcinoma" (6 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials) and "Cervical Adenocarcinoma" (5 trials). Many other conditions were trialed in "Northwestern Medicine Cancer Center Delnor" in a lesser frequency.

Most popular intervention types in "Northwestern Medicine Cancer Center Delnor" are "Drug" (111 trials), "Other" (98 trials), "Biological" (56 trials), "Procedure" (48 trials) and "Radiation" (40 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (51 trials), "Laboratory Biomarker Analysis" (42 trials), "Questionnaire Administration" (30 trials), "Computed Tomography" (26 trials) and "Biospecimen Collection" (19 trials). Other intervention names were less common.

The vast majority of trials in "Northwestern Medicine Cancer Center Delnor" are 101 trials for "All" genders, 32 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Northwestern Medicine Cancer Center Delnor". undefined are not yet recruiting, 44 are recruiting, 73 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Northwestern Medicine Cancer Center Delnor, 2 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Northwestern Medicine Cancer Center Delnor, 2 "Phase 1" clinical trials were conducted, 58 "Phase 2" clinical trials and 94 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".